Lipotris™

Product Description

Liposomal intra-articular gel composite - new generation viscosupplement which ensures supreme lubrication mechanism. Lipotris™ therapy provides accelerated pain relief with sustainable duration of clinical effect. The TRIAD OF AN IDEAL LUBRICATION provides ultra-low friction ratio between cartilage surfaces, due to interaction between lubricin and liposomes enveloped with HA chains in the form of intra-articular gel. 

Biovico Sp. z o.o.

  • Country/Region:
    Poland
  • Founded:
    2008
  • On CPHI since:
    2015
  • Certificates:
    5
  • Employees:
    100 - 249
Company types
CMO/CDMO
Licensee
Manufacturer/Innovator
Wholesale/Retail
Primary activities
Medical Devices
Specifications
  • Details
    Lipotris™ is a liposomal composite gel formed with a 44mg sodium hyaluronate and 1.6mg liposomes provided in a the injection of 2ml. The highly concentrated hyaluronic acid contained in Lipotris™ has precisely tailored physicochemical parameters, including an optimally high molecular weight. Additionally, Lipotris™ composite gel contains synthetic liposomes, created from phospholipids (1-palmitoyl-2-oleoyl-phosphatidylcholine, POPC) that have a strictly defined size.Dedicated to knees and other synovial joints.
  • Selling Points
    Bone & Joint Health; Brand Name; Lipotris™ is a composite of hyaluronic acid and liposomes that form a consolidated material.Upon intra-articular injection, Lipotris™ actively interacts with lubricin.Mentioned interaction transforms the motion in the joint from sliding to rolling, providing a surface with negligible friction, providing the correct, high-quality joint movement. For this reason, Lipotris™ therapy is able to provide an exceptionally rapid and long-lasting clinical response.Only three injections to achieve therapeutic effect.Provides immediate pain reliefand noticeable improvement inmobility. Proven to help patients with moderate to advanced osteoarthritis (grades II and III). Clinically proven to reduces joint pain andimproved OA patients quality of life.
  • Supplied from
    Poland

Biovico Sp. z o.o.

  • Country/Region:
    Poland
  • Founded:
    2008
  • On CPHI since:
    2015
  • Certificates:
    5
  • Employees:
    100 - 249
Company types
CMO/CDMO
Licensee
Manufacturer/Innovator
Wholesale/Retail
Primary activities
Medical Devices

More Products from Biovico Sp. z o.o. (12)

  • Biolevox™ HA

    Product Biolevox™ HA

    The Biolevox™ HA product family is based on hyaluronic acid with carefully selected concentration, viscosity and molecular parameters tailored to specific clinical applications.
    • Biolevox™ HA ONE delivers 120 mg of highly purified HA in a single injection. Its USP is clinically confirmed OA symptom ...
  • Xerthra™ kits

    Product Xerthra™ kits

    Xerthra™ is a family of high-performance separation devices for preparing autologous, blood-derived injectable products. Made from Makrolon® polycarbonate with very low surface energy, Xerthra™ minimizes protein/cell binding to the device surface — unlike tube-based kits — ensuring maximum recovery of plat...
  • Wint™ kit

    Product Wint™ kit

    Wint ™ is a unique, high-performance separation device designed to obtain blood derived product rich in DKK-1 (Dickkopf-1) protein- a natural, endogenous inhibitor or Wnt signaling pathway from patient's own blood. Wint™ separation device, due to presence of the exclusive borosilicate activator trigge...
  • FLAVYA™

    Product FLAVYA™

    Flavya™ products are injectable medical devices containing native hyaluronic acid (HA). Flavya™ complements HA deficiencies in dermis, attracts water molecules, neutralizes free radicals, creates conditions for regeneration processes and production of new collagen and elastin fibres in the skin.
    Two v...
  • DKK DERM™ kit

    Product DKK DERM™ kit

    DKK DERM™ kit is designed to obtain an autologous blood-derived product enriched with the DKK-1 protein (DKK-PRP). The DKK DERM™ separation device features an innovative borosilicate platelet activator that selectively induces platelet activation, leading to the release of hig...
  • Monoshot™ HA+PRP

    Product Monoshot™ HA+PRP

    Monoshot™ HA+PRP is an innovative kit combining hyaluronic acid (HA) with platelet-rich plasma (PRP) for intra-articular injection therapy. HA delivers mechanical lubrication and anti-inflammatory action by reducing matrix metalloproteinase production, while PRP — prepared using the dedicated Monoshot™ sep...
  • Xerthra™ BMAC

    Product Xerthra™ BMAC

    Xerthra™ BMAC is an innovative procedure set for separating and concentrating bone marrow aspirate to obtain a concentrated bone marrow fraction (BMAC), used for local injection to enhance tissue regeneration. Its uniquely designed separation devices deliver BMAC with 5 times more concentrated mesenchymal ...
  • AOORA™ kits

    Product AOORA™ kits

    Three AOORA™ procedure packs designed for isolation and separation of high quality blood derived products. The obtained platelet-rich plasma (PRP) contains minimum 1 milion of platelets in 1 μl of plasma, which has the direct impact on the high amount of growth factors delivered in order to revitalize skin...
  • Flavya™ Post Treatment products

    Product Flavya™ Post Treatment products

    Flavya™ Post-Treatment Products are biocellulose-based medical devices infusedwith hyaluronic acid. Due to their occlusive properties, they form a protective barrieron the skin, which is particularly beneficial after medical esthetic treatments.Additionally, their cooling effect helps soothe irritation and...
  • Supplements

    Product Supplements

    Biolevox™ Complex (90 film-coated capsules) supplements the diet with ingredients found in joint structures thus supports the their functioning.
    Chondrovox™ (60 capsules) formulation contains chondroitin sulfate that occurs naturally in joint cartilage. Chondroitin supplementation sup...
  • Progum™

    Product Progum™

    Progum™ is a hyaluronic acid-based product line supporting regeneration in dental and periodontal care. Progum™ HA is a highly concentrated, non-crosslinked native hyaluronic acid (16 mg HA in a 1 mL pre-filled syringe) with physicochemical parameters optimized to promote soft periodontal tissue regen...
  • Ossylbone™

    Product Ossylbone™

    Ossylbone™ is a fully biocompatible, biodegradable and safe material that mimics the natural bone structure and by that its able to effectively support the regeneration of the bone tissue.The Ossylbone™ as an alloplast material is bone substitute material obtained through laboratory chemical synt...

Biovico Sp. z o.o. resources (4)